Maven Health is a Swiss-based startup founded in 2024, specializing in metabolic health assessments for healthcare providers. The company offers an end-to-end solution for healthcare providers to test individuals with minimal invasiveness and competitive cost, enabling deep data interpretation and communication. Maven Health utilizes saliva as the bio-fluid for metabolite measurements, which are analyzed through custom analytical methods on nuclear magnetic resonance (NMR). The results are delivered on an easy-to-use, intuitive data platform for healthcare professionals. The latest investment for Maven Health was a Fr.10.00K grant received on 28 February 2024. This grant was provided by the Future of Health Grant and EPFL Innovation Park, signifying the recognition and support the company has garnered within the healthcare and innovation sectors. Maven Health operates at the intersection of AI, analytics, and healthcare, positioning itself as a promising venture for potential investors seeking innovative solutions at the forefront of metabolic health assessment.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | Fr.10.00K | 2 | Future of Health Grant, EPFL Innovation Park | 28 Feb 2024 |
Pre Seed Round | Fr.352.00K | 3 | Future of Health Grant, Foundation for Technological Innovation (FIT) | 09 Jan 2024 |
Non Equity Assistance | Fr.3.50K | 1 | DayOne accelerator | 01 Jun 2023 |
Pre Seed Round | Fr.20.00K | 1 | 28 Dec 2022 | |
Grant | Fr.30.00K | 1 | Federal Polytechnic School of Lausanne | 19 Dec 2022 |
No recent news or press coverage available for Maven Health.